Published in:
01-02-2017 | Brief Report
Almost 2% of Spanish breast cancer families are associated to germline pathogenic mutations in the ATM gene
Authors:
A. Tavera-Tapia, L. Pérez-Cabornero, J. A. Macías, M. I. Ceballos, G. Roncador, M. de la Hoya, A. Barroso, V. Felipe-Ponce, R. Serrano-Blanch, C. Hinojo, M. D. Miramar-Gallart, M. Urioste, T. Caldés, S. Santillan-Garzón, J. Benitez, A. Osorio
Published in:
Breast Cancer Research and Treatment
|
Issue 3/2017
Login to get access
Abstract
Purpose
There is still a considerable percentage of hereditary breast and ovarian cancer (HBOC) cases not explained by BRCA1 and BRCA2 genes. In this report, next-generation sequencing (NGS) techniques were applied to identify novel variants and/or genes involved in HBOC susceptibility.
Methods
Using whole exome sequencing, we identified a novel germline mutation in the moderate-risk gene ATM (c.5441delT; p.Leu1814Trpfs*14) in a family negative for mutations in BRCA1/2 (BRCAX). A case-control association study was performed to establish its prevalence in Spanish population, in a series of 1477 BRCAX families and 589 controls further screened, and NGS panels were used for ATM mutational screening in a cohort of 392 HBOC Spanish BRCAX families and 350 patients affected with diseases not related to breast cancer.
Results
Although the interrogated mutation was not prevalent in case-control association study, a comprehensive mutational analysis of the ATM gene revealed 1.78% prevalence of mutations in the ATM gene in HBOC and 1.94% in breast cancer-only BRCAX families in Spanish population, where data about ATM mutations were very limited.
Conclusion
ATM mutation prevalence in Spanish population highlights the importance of considering ATM pathogenic variants linked to breast cancer susceptibility.